| Autophagy in Parkinson's disease X Hou, JO Watzlawik, FC Fiesel, W Springer Journal of molecular biology 432 (8), 2651-2672, 2020 | 285 | 2020 |
| Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases M Allen, X Wang, JD Burgess, J Watzlawik, DJ Serie, CS Younkin, ... Alzheimer's & dementia 14 (3), 352-366, 2018 | 125 | 2018 |
| Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes J Watzlawik, E Holicky, DD Edberg, DL Marks, AE Warrington, BR Wright, ... Glia 58 (15), 1782-1793, 2010 | 78 | 2010 |
| PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation JO Watzlawik, AE Warrington, M Rodriguez PloS one 8 (2), e55149, 2013 | 77 | 2013 |
| Prion protein helix1 promotes aggregation but is not converted into β-sheet J Watzlawik, L Skora, D Frense, C Griesinger, M Zweckstetter, ... Journal of Biological Chemistry 281 (40), 30242-30250, 2006 | 76 | 2006 |
| Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination J Watzlawik, AE Warrington, M Rodriguez Expert review of neurotherapeutics 10 (3), 441-457, 2010 | 55 | 2010 |
| High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance NJ Wittenberg, H Im, X Xu, B Wootla, J Watzlawik, AE Warrington, ... Analytical chemistry 84 (14), 6031-6039, 2012 | 49 | 2012 |
| Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology X Hou, JO Watzlawik, C Cook, CC Liu, SS Kang, WL Lin, M DeTure, ... Alzheimer's & Dementia 17 (3), 417-430, 2021 | 41 | 2021 |
| Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples JO Watzlawik, X Hou, D Fricova, C Ramnarine, SK Barodia, TF Gendron, ... Autophagy 17 (9), 2613-2628, 2021 | 38 | 2021 |
| ABCA7 loss-of-function variants, expression, and neurologic disease risk M Allen, SJ Lincoln, M Corda, JO Watzlawik, MM Carrasquillo, JS Reddy, ... Neurology: Genetics 3 (1), e126, 2017 | 35 | 2017 |
| Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150-kDa oligomers formed by amyloid-β (1–42) Y Gao, C Guo, JO Watzlawik, PS Randolph, EJ Lee, D Huang, SM Stagg, ... Journal of molecular biology 432 (16), 4388-4407, 2020 | 33 | 2020 |
| VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells RS Angom, Y Wang, E Wang, K Pal, S Bhattacharya, JO Watzlawik, ... The FASEB Journal 33 (3), 4626, 2019 | 32 | 2019 |
| Recent advances in monoclonal antibody therapies for multiple sclerosis B Wootla, JO Watzlawik, N Stavropoulos, NJ Wittenberg, H Dasari, ... Expert opinion on biological therapy 16 (6), 827-839, 2016 | 28 | 2016 |
| Antiviral protection via RdRP-mediated stable activation of innate immunity MM Painter, JH Morrison, LJ Zoecklein, TA Rinkoski, JO Watzlawik, ... PLoS pathogens 11 (12), e1005311, 2015 | 28 | 2015 |
| Antibody-mediated oligodendrocyte remyelination promotes axon health in progressive demyelinating disease B Wootla, A Denic, JO Watzlawik, AE Warrington, M Rodriguez Molecular neurobiology 53, 5217-5228, 2016 | 25 | 2016 |
| A patterned recombinant human IgM guides neurite outgrowth of CNS neurons X Xu, NJ Wittenberg, LR Jordan, S Kumar, JO Watzlawik, AE Warrington, ... Scientific reports 3 (1), 2267, 2013 | 23 | 2013 |
| Naturally occurring monoclonal antibodies and their therapeutic potential for neurologic diseases B Wootla, JO Watzlawik, AE Warrington, NJ Wittenberg, A Denic, X Xu, ... JAMA neurology 72 (11), 1346-1353, 2015 | 22 | 2015 |
| Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire JO Watzlawik, B Wootla, MM Painter, AE Warrington, M Rodriguez Expert review of neurotherapeutics 13 (9), 1017-1029, 2013 | 22 | 2013 |
| Tryptophan catabolites and their impact on multiple sclerosis progression J O Watzlawik, B Wootla, M Rodriguez Current pharmaceutical design 22 (8), 1049-1059, 2016 | 21 | 2016 |
| Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice JO Watzlawik, RJ Kahoud, RJ O’Toole, KAM White, AR Ogden, ... PloS one 10 (5), e0128007, 2015 | 21 | 2015 |
